InvestorsHub Logo
icon url

Tadasana

11/10/17 4:07 PM

#142446 RE: exwannabe #142428

Hey ex, you got world's top neurosurgeon Dr.Linda Liau MD,PhD,MBA Chairman of UCLA Neurosurgery Dept. Principle investigator of DC-Vax L tell you there is EFFICACY! What else you wanna know? Forget I asked the ? You seem to know more than her... must of been a top neurosurgeon in your previous life. You know it all... Congrats! oh yeah forget about the 98 still alive patients... and why did they choose her as Chairperson of the UCLA Neurosurgery Dept?
icon url

Doc logic

11/10/17 4:52 PM

#142454 RE: exwannabe #142428

exwannabe,

I think the EAP was discussed by NWBO indirectly by stating the costs involved for restart being prohibitive and, at the point they were at, unnecessary. As for the difference between your option A and B, in option A FDA knows they are randomizing into a trial where there may have been a clear difference seen. By assigning these patients to other options including other trials they have no sure way of knowing thus solving the ethical dilema. Best wishes.